The NPC Standing Committee on June 24, 2022 enacted the Amended Anti-monopoly Law, which entered into force on August 1, 2022 (the "amended Anti-monopoly Law").

China's pharmaceutical industry is witnessing a notable surge in "pipeline spin-off projects", a model commonly referred to as the "Spin-off-NewCo" or "SON"...

On April 4, 2023, the Ministry of Science and Technology released the "Measures for Science and Technology Ethics Review (Trial) (Draft for Comments)" ("Draft for Comments")...

On November 7, 2016, the Network Security Law of the People's Republic of China was adopted at the twenty-fourth meeting of the 12th National People's Congress after the third draft.

在本篇文章中，我们将继续对新三板挂牌企业申报IPO涉及的挂牌期间股份交易情况、申报前一年新增股东披露、新三板信息披露文件与IPO申报文Ê

2023年2月24日，香港联合交易所有限公司（"香港联交所"）刊发了咨询文件（"咨询文件"）...

On February 24, 2023, The Stock Exchange of Hong Kong Limited ("HKEX") published a consultation paper (the "Consultation Paper"), which detailed the proposed amendments to the Rules Governing...

On September 8, 2023, the China Biotechnology Development Center directly under the Ministry of Science and Technology of the People's Republic of China...

Based on our experience, many projects that consider multiple factors and make separate arrangements for econo

For a long time, overseas listing of domestic enterprises has been one of the major ways for investment institutions to exit. The filing-based system for overseas offering and listing adopts...

Recently, the National Medical Products Administration (the "NMPA") issued the "Pilot Work Plan for Segmented Production of Biological Products" (the "Pilot Plan"), introducing the pilot initiative for the segmented production of biological products.

Recently, it was rumored on the Internet that the Department of Drug Registration Management of the State Medical Products Administration issued the "Letter on Strengthening the Daily Supervision...

其中，第（一）和（二）项属于风险防御能力评估条款，第（三）和（四）项属于主动侵害行为禁止条款，如此规定，可谓正反兼顾。但总体

2022年4月11日，国家药品监督管理局（" 国家药监局"）发布了《药品年度报告管理规定》以及相应的报告模板（以下合称" 《年报规定》"）...

2022 年 7 月 7 日，国家互联网信息办公室（"网信办"）正式发布《数据出境安全评估办法》（"《评 估办法》"），...

In essence, the Guidelines show very few modifications from the version previously issued to certain invited Foreign NGOs for comment.

A Brief Overview of the Pilot Program for Foreign-funded Equity Investment Enterprises

On November 13, 2024, the National Medical Products Administration (the "NMPA") issued the Interim Provisions on the Management of Domestic Responsible Entity Designated by Overseas Marketing Authorization Holders (hereinafter referred to as the "Regulations on Domestic Responsible Entities").

China's National Medical Products Administration (NMPA) released the 2023 Drug Review Annual Report on its official website on February 4, 2024...

China's sports arbitration system was previously set out in Article 32 of the Law of the People's Republic of China on Physical Culture and Sports (the "Sports Law", as amended in 2016)...